SCHEMBL6462336

SCHEMBL6462336

O=C(O)NCCCCC(=O)NCCC(C(=O)c1nccs1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 9/20 0.47
HDAC3 O15379 8/20 0.47
HDAC6 Q9UBN7 8/20 0.43
HDAC4 P56524 3/20 0.43
HDAC7 Q8WUI4 3/20 0.43
HDAC2 Q92769 3/20 0.43
HDAC10 Q969S8 3/20 0.43
HDAC11 Q96DB2 3/20 0.43
HDAC8 Q9BY41 3/20 0.43
HDAC9 Q9UKV0 3/20 0.43
HDAC5 Q9UQL6 3/20 0.43
PLA2G4A P47712 1/20 0.41
CES1 P23141 1/20 0.41
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467052 0.82 HDAC1 (0.47) HDAC1HDAC3HDAC6HDAC4HDAC7
SCHEMBL6466422 0.82 HDAC6 (0.50) HDAC1HDAC3HDAC6HDAC4HDAC7
SCHEMBL6464482 0.82 CYP1A2 (0.41) CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9
SCHEMBL6676845 0.76 CYP1A2 (0.43) CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9
SCHEMBL6467339 0.75 HDAC1 (0.58) HDAC1HDAC3HDAC6HDAC2HDAC8
SCHEMBL6062993 0.75 EPHX2 (0.41) CYP3A4CYP2D6CYP2C19CYP1A2CYP2C9
SCHEMBL6466215 0.72 SMN1; SMN2 (0.42) HDAC1HDAC3HDAC6HDAC4HDAC7
SCHEMBL7043362 0.72 KCNA5 (0.39) HDAC6CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL31530570 0.64 LMNA (0.46) HDAC1HDAC3PLA2G4ACES1CYP3A4
SCHEMBL2631739 0.64 HDAC1 (0.60) HDAC1HDAC3HDAC6PLA2G4ACES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed